Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure

PHASE3CompletedINTERVENTIONAL
Enrollment

257

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Heart FailureDyspnea
Interventions
DRUG

Tolvaptan

IV furosemide plusTolvaptan (given at 0, 24 and 48 hours)

DRUG

Placebo

IV furosemide plus oral placebo (given at 0, 24 and 48 hours)

Trial Locations (18)

10461

Montefiore Medical Center, The Bronx

15065

Allegheny Valley Hospital, Natrona Heights

18960

Grand View - Lehigh Valley Health Services, Sellersville

22042

Inova Heart and Vascular Institute, Falls Church

27599

University of North Carolina at Chapel Hill, Chapel Hill

27713

Duke University Medical Center, Durham

28204

Novant Health Heart and Vascular, Charlotte

28358

Southeastern Regional Medical Center, Lumberton

30322

Emory University School of Medicine, Atlanta

30501

Northeast Georgia Heart Center, Gainesville

31201

Mercer University School of Medicine, Macon

45219

The Christ Hospital, Cincinnati

45267

University of Cincinnati Medical Center, Cincinnati

46202

Indiana University School of Medicine, Indianapolis

55415

Hennepin County Medical Center, Minneapolis

60637

University of Chicago, Chicago

75390

UT Southwestern Medical center, Dallas

80045

University of Colorado at Denver and Health Sciences Center, Aurora

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Duke University

OTHER